Novavax Inc. (NVAX) reported a transaction involving Ruxandra Draghia-Akli, a person with a Section 16 relationship to the issuer, according to a recent filing. The transaction occurred on 11/11/2024. However, the filing did not disclose specific details such as the action type, status, number of shares, nature of shares, transaction price, or the total value of shares involved. The number of shares held by Draghia-Akli after the action was also not provided. Investors are advised to await further details to fully assess the impact of this transaction on their investment decisions.

Novavax Inc. (NVAX) reported a transaction involving Ruxandra Draghia-Akli, a person with a Section 16 relationship to the issuer, according to a recent filing. The transaction occurred on 11/11/2024. However, the filing did not disclose specific details such as the action type, status, number of shares, nature of shares, transaction price, or the total value of shares involved. The number of shares held by Draghia-Akli after the action was also not provided. Investors are advised to await further details to fully assess the impact of this transaction on their investment decisions.